Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (201-210 of 631) with videos related to

Pageof 64
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|May 9, 2022
Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?Daniel Seehofer, Henrik Petrowsky, Stefan Schneeberger, et al.
Biomedicines|February 25, 2022
Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver DiseaseAlbrecht Boehlig, Florian Gerhardt, David Petroff, et al.
Journal of Hepatology|November 26, 2002
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis CMarkus Cornberg, Holger Hinrichsen, Gerlinde Teuber, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis CViola Knop, Alexandra Bergk, Beate Schlosser, et al.
Trends in Molecular Medicine|June 12, 2010
Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategiesPhilippe Georgel, Catherine Schuster, Mirjam B Zeisel, et al.
Plos One|July 21, 2017
Low PCSK9 levels are correlated with mortality in patients with end-stage liver diseaseValentin Schlegel, Theresa Treuner-Kaueroff, Daniel Seehofer, et al.
Journal of Hepatology|February 24, 2016
Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015Johannes Wiegand, Florian van Bömmel, Andrés Duarte-Rojo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2017
Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver DiseaseJohannes Remmler, Christoph Schneider, Theresa Treuner-Kaueroff, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapyDennis Eurich, Marcus Bahra, Thomas Berg, et al.
Clinical Chemistry and Laboratory Medicine|March 1, 2020
Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidatesMitja L Heinemann, Louis Elsing, Thorsten Kaiser, et al.
Pageof 64

Showing results (201-210 of 631) with videos related to

Sort By:
Pageof 64
Transplant International : Official Journal of the European Society for Organ Transplantation|May 9, 2022
Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?Daniel Seehofer, Henrik Petrowsky, Stefan Schneeberger, et al.
Biomedicines|February 25, 2022
Prevalence of Pruritus and Association with Anxiety and Depression in Patients with Nonalcoholic Fatty Liver DiseaseAlbrecht Boehlig, Florian Gerhardt, David Petroff, et al.
Journal of Hepatology|November 26, 2002
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis CMarkus Cornberg, Holger Hinrichsen, Gerlinde Teuber, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Bezafibrate maintenance therapy in patients with advanced chronic hepatitis CViola Knop, Alexandra Bergk, Beate Schlosser, et al.
Trends in Molecular Medicine|June 12, 2010
Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategiesPhilippe Georgel, Catherine Schuster, Mirjam B Zeisel, et al.
Plos One|July 21, 2017
Low PCSK9 levels are correlated with mortality in patients with end-stage liver diseaseValentin Schlegel, Theresa Treuner-Kaueroff, Daniel Seehofer, et al.
Journal of Hepatology|February 24, 2016
Clinical Trial Watch: Reports from the Liver Meeting®, AASLD, San Francisco, November 2015Johannes Wiegand, Florian van Bömmel, Andrés Duarte-Rojo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2017
Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver DiseaseJohannes Remmler, Christoph Schneider, Theresa Treuner-Kaueroff, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapyDennis Eurich, Marcus Bahra, Thomas Berg, et al.
Clinical Chemistry and Laboratory Medicine|March 1, 2020
Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidatesMitja L Heinemann, Louis Elsing, Thorsten Kaiser, et al.
Pageof 64